Protocadherin-1: epithelial barrier dysfunction in asthma and eczema Source: Eur Respir J 2014; 43: 671-674 Year: 2014
From atopic dermatitis to asthma what drives the allergic march? Source: Eur Respir J 2003; 22: Suppl. 45, 137s Year: 2003
Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002
Role of atopic dermatitis as a risk factor for allergic rhinitis in children Source: Annual Congress 2010 - Paediatric epidemiology: asthma and associated factors Year: 2010
Airway inflammation and lung function in atopic and non-atopic rhinitis Source: International Congress 2018 – Epidemiology of asthma and allergy: prevalence, incidence and risk factors Year: 2018
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia Source: Eur Respir J 2014; 44: 239-241 Year: 2014
Epithelial inflammation, damage and proliferation after allergen exposure in atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 207s Year: 2002
Allergic inflammation markers for earlier diagnosis of bronchial asthma in patients with allergic rhinitis Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
The structure of sensitization to aeroallergens in children with atopic bronchial asthma Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019
Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The march from subclinical small-airways dysfunction to asthma in children with allergic rhinitis Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019
Effects of a 12-month course with omalizumab on nasal polyps and basement membrane in severe atopic asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Angiogenesis in the airway wall of atopic children without asthma Source: Eur Respir J 2006; 28: Suppl. 50, 599s Year: 2006
Omalizumab in severe adult atopic dermatitis associated to mild asthma treated with omalizumab Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012
Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001
Distinct epithelial gene expression phenotypes in childhood respiratory allergy Source: Eur Respir J 2012; 39: 1197-1205 Year: 2012
The role of mast cells in allergic, non-allergic and aspirin-induced asthma and rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 589s Year: 2005
The occurrence of atopic dermatitis associated with asthma in Paracin region Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005
Rhinitis prevalence and its relationship with asthma, atopic dermatitis and allergic sensitization in school children Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008